hotspot -WSS

hotspot

author：explore 2025-09-28 21:04:29 - browse：991

James Comer -- coverage from STAT — Rep. James Comer, chair of the House Oversight Committee Kevin Dietsch/Getty Images

WASHINGTON — Congress wants to reform PBM business practices to help lower the cost of medicines — but don’t think they’ve forgotten drugmakers have a role in high drug prices.

Two lawmakers, including a Republican, questioned PhRMA Chief Operating Officer Lori Reilly about just how much her group was spending on its major campaigns against PBMs this year. Both Reps. Summer Lee (D-Pa.) and Eric Burlison (R-Mo.) used their time to question drugmakers over their spending on lawsuits against Medicare drug price negotiation and ad campaigns against pharmacy benefit managers.

Although Lee started off bashing PBMs for the fees they charge drugmakers, she quickly aimed her fire back on pharma. She said brand drugmakers charge Americans double what they charge other countries, and she asked why several drugmakers are suing the federal government over Medicare’s drug price negotiation.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： eGenesis tests gene

knowledge

WSS

Independent physicians launch a new lobbying group

In diabetes hearing, Sanders takes on a new foe: food makers

Parkinson’s finding may lead to tests and, someday, treatments

Leukemia patients are helped by Syndax's new type of therapy

Independent physicians launch a new lobbying group

Americans' trust in science, scientist continues decline: Report

knowledge

hotspot

focus

Activists slam private health insurers over coverage restrictions

AI models in health care face new federal disclosure requirements

Medical records are filled with copy

Americans' trust in science, scientist continues decline: Report

Duchenne breakthrough therapy leaves behind pioneering families

NIH director takes cautious approach to Biden drug pricing priority

23andMe had bad news about my health. I wish a person had delivered it

AbbVie buys Immunogen, maker of targeted cancer drugs, for $10B

Malaria cases in Florida and Texas: Here’s what you need to know

Dewpoint Therapeutics lays off staff after losing partnerships

leisure time

Supreme Court wrestles with OxyContin maker's bankruptcy deal

New brain studies show LSD's effects on the brain in full color

My yearlong odyssey to get my son’s ADHD medication covered

EU regulator recommends expanding Mounjaro approval to obesity

New brain studies show LSD's effects on the brain in full color

Francis Collins on trust in science and how Covid communications failed

entertainment

knowledge

knowledge

hotspot